News | December 30, 2022
Cipla EU to invest € 15 million in Ethris
Cipla and Ethris partner for the development of mRNA-based therapies
Cipla and Ethris partner for the development of mRNA-based therapies
All claims against the company in the litigation have now been dismissed.
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Surana is a chartered accountant with an all-India rank.
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The scheme is subject to statutory and regulatory approvals as may be necessary.
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
As a result, Imago will become a subsidiary of Merck.
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Subscribe To Our Newsletter & Stay Updated
